![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 38/08 | (2019.01) |
(11) | Number of the document | 3230318 |
(13) | Kind of document | T |
(96) | European patent application number | 15793746.7 |
Date of filing the European patent application | 2015-11-04 | |
(97) | Date of publication of the European application | 2017-10-18 |
(45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
(46) | Date of publication of the claims translation | 2020-10-12 |
(86) | Number | PCT/EP2015/075722 |
Date | 2015-11-04 |
(87) | Number | WO 2016/091487 |
Date | 2016-06-16 |
(30) | Number | Date | Country code |
201422084 | 2014-12-11 | GB | |
201506127 | 2015-04-10 | GB | |
2015118495 | 2015-06-11 | JP |
(72) |
EIKE, Liv Marie, NO
CAMILIO, Ketil, NO
SVEINBJORNSSON, Baldur, NO
ZITVOGEL, Laurence, FR
YAMAZAKI, Takahiro, FR
REKDAL, Oystein, NO
SVENDSEN, John Sigurd Mj en, NO
|
(73) |
Lytix Biopharma AS,
Tromso Science Park P.O. Box 6447, 9294 Tromso,
NO
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Imuninės kontrolės taško inhibitorių kombinacijos |
IMMUNE CHECKPOINT INHIBITOR COMBINATIONS |
Payment date | Validity (years) | Amount | |
2021-10-22 | 7 | 162.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2022-11-04 |